Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner.
about
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating PeptideCuraxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF‑β signaling.Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells.
P2860
Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@en
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@nl
type
label
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@en
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@nl
prefLabel
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@en
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of HIV-1 reactivati ...... e in a HSP90-dependent manner.
@en
P2093
Bum-Joon Kim
Kyung-Soo Inn
Myung-Soo Choi
P2860
P2888
P356
10.1038/SREP28896
P407
P577
2016-07-01T00:00:00Z